CA2216700C - Compositions pharmaceutiques a effet synergique a base d'acetonide de triamcinolone et de halcinonide - Google Patents
Compositions pharmaceutiques a effet synergique a base d'acetonide de triamcinolone et de halcinonide Download PDFInfo
- Publication number
- CA2216700C CA2216700C CA002216700A CA2216700A CA2216700C CA 2216700 C CA2216700 C CA 2216700C CA 002216700 A CA002216700 A CA 002216700A CA 2216700 A CA2216700 A CA 2216700A CA 2216700 C CA2216700 C CA 2216700C
- Authority
- CA
- Canada
- Prior art keywords
- treatment
- halcinonide
- triamcinolone acetonide
- psoriasis
- figures
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Une composition pharmaceutique est constituée d'une association synergique contenant, comme principes actifs, au moins environ 0,01 % en poids d'acétonide de triamcinolone et au moins environ 0,01 % en poids de halcinonide, en association avec un excipient pharmaceutiquement acceptable.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1995/009544 WO1996003132A1 (fr) | 1994-07-28 | 1995-07-27 | Compositions pharmaceutiques a effet synergique a base d'acetonide de triamcinolone et de halcinonide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2216700A1 CA2216700A1 (fr) | 1996-02-08 |
| CA2216700C true CA2216700C (fr) | 2002-09-17 |
Family
ID=22249542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002216700A Expired - Fee Related CA2216700C (fr) | 1995-07-27 | 1995-07-27 | Compositions pharmaceutiques a effet synergique a base d'acetonide de triamcinolone et de halcinonide |
Country Status (3)
| Country | Link |
|---|---|
| CA (1) | CA2216700C (fr) |
| DE (1) | DE69506288T2 (fr) |
| DK (1) | DK0840613T3 (fr) |
-
1995
- 1995-07-27 CA CA002216700A patent/CA2216700C/fr not_active Expired - Fee Related
- 1995-07-27 DE DE69506288T patent/DE69506288T2/de not_active Expired - Lifetime
- 1995-07-27 DK DK95929328T patent/DK0840613T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| DE69506288D1 (de) | 1999-01-07 |
| DK0840613T3 (da) | 2000-08-28 |
| DE69506288T2 (de) | 1999-06-24 |
| CA2216700A1 (fr) | 1996-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4670471A (en) | Treatment for inflammatory skin disease | |
| EP0840613B1 (fr) | Compositions pharmaceutiques a effet synergique a base d'acetonide de triamcinolone et de halcinonide | |
| IL95820A (en) | Preparations for the treatment of inflammatory or allergic painful physical defects containing SIC-8-methyl-N- and anilyl-6-nonanamide | |
| CA2408541C (fr) | Traitement contre l'eczema et/ou le psoriasis | |
| US6613800B1 (en) | Method and compositions for treating psoriasis, eczema, seborrhea and arthritis | |
| EP0908183A1 (fr) | Déhydroépiandrostérone ou ses dérivés pour augmenter la quantité d'acide hyaluronique dans la peau | |
| AU2001260833A1 (en) | Treating eczema and/or psoriasis | |
| JP2008502659A (ja) | 乾癬の治療のための、クロベタゾールプロピオネートとカルシトリオールとを含む製薬組成物の使用 | |
| US8586064B2 (en) | Treating eczema and/or psoriasis | |
| US4119713A (en) | Analgesic and anti-inflammatory composition | |
| CA2216700C (fr) | Compositions pharmaceutiques a effet synergique a base d'acetonide de triamcinolone et de halcinonide | |
| GB2079151A (en) | Medication for relief of intra-articular and intra-muscular discomfort | |
| WO2003061676A1 (fr) | Compositions et procedes de traitement de troubles cutanes | |
| EP0916341A2 (fr) | Compositions pharmaceutiques à effet synergique à base d'acétonide de triamcinolone et de halcinonide | |
| Iijima et al. | Contact immunotherapy with squarid acid dibutylester for warts | |
| AU701833B2 (en) | Psoriasis treatment | |
| JPH03227921A (ja) | ケロイド治療剤 | |
| JPH06199672A (ja) | 活性成分としてクロラムフェニコール、ゲンタマイシンおよびナイスタチンを含有する、炎症性皮膚疾患の局所治療のための配合製剤 | |
| US20040204492A1 (en) | Topical composition and method for treating seborrheic dermatitis | |
| AU2011269256B2 (en) | Agent for the treatment of skin conditions | |
| Clyman | Comparative Effects of Hydrocortisone and Hydrocortisone-Coal Tar Extract Creams in Cases of Atopic Dermatitis | |
| WO1994005301A1 (fr) | Compositions destinees au traitement de la dermite, contenant du soufre, de l'acide salicylique et du dimethylsulfone | |
| CA2121783A1 (fr) | Compositions pharmaceutiques antisporiasiques et procede d'obtention | |
| NZ522434A (en) | Treating eczema and/or psoriasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20130729 |